Organic compounds as fragrances
Oxamacrocyclic ketones with specific divalent residues offer musky, powdery, and nitro musk notes, addressing the lack of such fragrances in the industry and enhancing product aromas.
Patent Information
- Application Number
- JP2024529963
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-22
- Filing Date
- 2022-11-21
- Publication Date
- 2024-11-06
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
There is a lack of compounds in the fragrance industry that possess unique musky, nitro-musk notes without sweet scent characteristics, and existing nitro musk compounds are of limited use.
Development of oxamacrocyclic ketones with specific divalent residues (X and Y) of varying lengths, excluding oxacyclohexadecane-6-one, to create compounds with musky, powdery nitro musk fragrance notes.
The compounds provide musky, powdery, and nitro musk fragrance notes, enhancing the aroma profiles of consumer products.
Smart Images

Figure 2024541099000001 
Figure 2024541099000002 
Figure 2024541099000003
Abstract
Description
[Technical field]
[0001] The present invention relates to fragrance ingredients and fragrance preparations for imparting desired odor notes to consumer products, and in particular to a novel class of oxamacrocyclic ketones of formula (I) which possess musky, powdery, nitromusk odor characteristics. [Background technology]
[0002] In the fragrance and flavor industry, perfumers and flavorists are continually searching for new compounds that possess unique odor characteristics.
[0003] Compounds with musk odor characteristics are well known in the art. The best known and commercially established cyclic compounds that possess musk odor characteristics are selected from the chemical classes of macrocyclic ketones such as mucenone (3-methylcyclopentadec-5-en-1-one), lactones such as Exaltolid™ (16-oxacyclohexadecan-1-one) or Nirvanolide® (13-methyloxacyclopentadec-10-en-2-one), and oxalactones such as Musk R1® (1,7-dioxacycloheptadecan-8-one).
[0004] However, little is known about oxacyclic ketones in the art.This class of compounds is mainly described in the literature as intermediates, for example for the preparation of macrocyclic lactones (KC Nicolaou et al., J. Am. Chem. Soc. 1998, 120, 5132-5133).As a further example, German patent application DE10163579A1 can be mentioned, which describes a process for the oxidation of oxacycloalkane derivatives to oxacycloalkanedione derivatives (for example, 1-oxacyclohexadecane-5-one to 1-oxacyclohexadecane-2,13-dione) using a liquid multiphase catalytic system that contains at least one ruthenium-containing compound and oxygen atoms.
[0005] There is only one document entitled "Many-membered cyclic oxides and oxido ketones" from 1936, which reveals some aroma properties (Stoll et al., Helv. Chim. Acta, 1936 (19), 735 - 743). The only oxido ketone disclosed is 1,15-oxido-pentadecanone-5 (oxacyclohexadecan-6-one), an isomer of Exaltolid™. According to the authors, the aroma properties of oxacyclohexadecan-6-one have changed completely compared to Exaltolid™. Among other things, oxacyclohexadecan-6-one presents a strong sweet note, partly reminiscent of vanillin, with some oily nuances, although the musk odor is maintained.
[0006] The main objective of the present invention was to find new substances that possess interesting odor characteristics and are suitable as fragrances for use in perfumery, in particular musky, nitro-musk notes, lacking sweet odor characteristics.
[0007] Compounds that possess typical nitro musk characteristics, such as Musk Ketone™ (1-(4-tert-butyl-2,6-dimethyl-3,5-dinitrophenyl)ethanone), have limited use, and thus there is particular interest in novel compounds that possess the desired odor reminiscent of nitro musk. Summary of the Invention
[0008] Thus, according to a first aspect of the present invention, a compound of formula (I) [ka] During the ceremony, X is a divalent residue -(CH2) optionally substituted with one additional methyl group. n- and Y is a divalent residue -(CH2) m - and n is an integer selected from 3 to 12, and m is an integer selected from 3 to 12; with the proviso that n+m is at least 13 and not more than 15, e.g., n+m is 14; and However, the compound represented by formula (I) is not oxacyclohexadecan-6-one. The use of the compound as a fragrance is provided.
[0009] In another specific embodiment, the compound of formula (I), X is a divalent residue -(CH2) substituted with one additional methyl group n- and Y is a divalent residue -(CH2) m - and n is an integer selected from 3 and 4; m is an integer selected from 9 to 11; provided that n+m is at least 13 and not more than 15, for example, n+m is 14; The use of the compound as a fragrance is provided.
[0010] In another specific embodiment, the compound of formula (I), X is a divalent residue -(CH2) n- and Y is a divalent residue -(CH2) m - and n is an integer selected from 3 to 7, and m is an integer selected from 7 to 12; with the proviso that n+m is at least 13 and not more than 15, e.g., n+m is 14; and However, the compound represented by formula (I) is not oxacyclohexadecan-6-one. The use of the compound as a fragrance is provided.
[0011] In another specific embodiment, the compound of formula (I), X is a divalent residue -(CH2) n- and Y is a divalent residue -(CH2) m - and n is an integer selected from 6, 7, and 8; and m is an integer selected from 6, 7, and 8; provided that n+m is at least 13 and not more than 15, for example, n+m is 14; The use of the compound as a fragrance is provided.
[0012] In another specific embodiment, the compound of formula (I), X is a divalent residue -(CH2) n- and Y is a divalent residue -(CH2) m - and n is an integer selected from 6 and 7, and m is an integer selected from 6 to 9; provided that n+m is at least 13 and not more than 15, for example, n+m is 14; The use of the compound as a fragrance is provided.
[0013] In another aspect there is provided the use of a compound of formula (I) selected from the group consisting of 4-methyloxacyclopentadecan-6-one; 3-methyloxacyclopentadecan-5-one; oxacyclopentadecan-5-one; oxacyclopentadecan-6-one; oxacyclopentadecan-7-one; oxacyclopentadecan-8-one; 3-methyloxacyclohexadecan-5-one; 4-methyloxacyclohexadecan-6-one; oxacyclohexadecan-5-one; oxacyclohexadecan-7-one; oxacyclohexadecan-8-one; oxacycloheptadecan-5-one; oxacycloheptadecan-6-one; oxacycloheptadecan-7-one; oxacycloheptadecan-8-one; and oxacycloheptadecan-9-one as a fragrance. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0014] The compound of formula (I), in which X is a divalent residue substituted with one methyl group, contains one chiral center and therefore may exist as a mixture of stereoisomers or it may be resolved as isomerically pure forms. Because resolving stereoisomers increases the complexity of the manufacture and purification of these compounds, it is preferred, simply for economic reasons, to use the compounds as a mixture of their stereoisomers. However, if it is desired to prepare individual stereoisomers, this can be achieved by methodologies known in the art, such as preparative HPLC and GC or stereoselective synthesis.
[0015] The compounds of formula (I) may be used alone, as their isomeric mixtures or in combination with known odorant molecules selected from a wide range of natural and currently available synthetic molecules such as essential oils, alcohols, aldehydes and ketones, ethers and acetals, esters and lactones, macrocycles and heterocycles, and / or in admixture with one or more ingredients or excipients conventionally used in conjunction with odorants in fragrance compositions, such as carrier materials and other auxiliaries commonly used in the art.
[0016] As used herein, "carrier material" means a material that is substantially neutral from the aroma point of view, ie a material that does not significantly alter the organoleptic properties of the aroma.
[0017] The term "auxiliary" refers to an ingredient that may be employed in a fragrance composition for reasons that are not specifically related to the olfactory performance of said composition. For example, an adjuvant may be an ingredient that acts as an adjuvant for processing the fragrance ingredient(s) or ingredients, or the composition containing said ingredient(s), or it may improve the handling or storage of the fragrance ingredient or the composition containing it. It may also be an ingredient that provides additional benefits, such as imparting color or texture. It may also be an ingredient that imparts lightfastness or chemical stability to one or more ingredients contained in the fragrance composition. A detailed description of the nature and type of adjuvants commonly used in fragrance compositions containing it is not exhaustive, but it must be mentioned that said ingredients are well known to those skilled in the art.
[0018] As used herein, "fragrance composition" refers to a composition comprising a compound of formula (I), or a mixture thereof, and a base material, e.g., diluents typically used in combination with fragrances, such as diethyl phthalate (DEP), dipropylene glycol (DPG), isopropyl myristate (IPM), pentane-1,2-diol, triethyl citrate (TEC) and alcohol (e.g., ethanol). Optionally, the composition may include an antioxidant adjuvant. The antioxidant may be selected from Tinogard® TT (BASF), Tinogard® Q (BASF), tocopherol (including its isomers, CAS 59-02-9; 364-49-8; 18920-62-2; 121854-78-2), 2,6-bis(1,1-dimethylethyl)-4-methylphenol (BHT, CAS 128-37-0), and the related phenol, hydroquinone (CAS 121-31-9).
[0019] The following list includes examples of known odorant molecules that can be combined with a compound of formula (I), or a mixture thereof: essential oils and extracts, such as bead on the columbine, costus root oil, oak moss absolute, geranium oil, tree moss absolute, basil oil, fruit oils such as bergamot oil and mandarin oil, myrtle oil, palmarosa oil, patchouli oil, petitgrain oil, jasmine oil, rose oil, sandalwood oil, absinthe oil, lavender oil and / or ylang-ylang oil;
[0020] alcohols, such as cinnamic alcohol ((E)-3-phenylprop-2-en-1-ol); cis-3-hexenol ((Z)-hex-3-en-1-ol); citronellol (3,7-dimethyloct-6-en-1-ol); dihydromyrcenol (2,6-dimethyloct-7-en-2-ol); Ebanol™ ((E)-3-methyl-5-(2,2,3-trimethylcyclopenta- 3-en-1-yl)pent-4-en-2-ol;Eugenol (4-allyl-2-methoxyphenol);Ethyl linalool ((E)-3,7-dimethylnona-1,6-dien-3-ol);Farnesol ((2E,6Z)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol);Geraniol ((E)-3,7-dimethylocta-2,6-dien-1-ol);Super Muguet™ ((E)-6-ethyl-3-methyloct-6-en-1-ol); Linalool (3,7-dimethylocta-1,6-dien-3-ol); Menthol (2-isopropyl-5-methylcyclohexanol); Nerol (3,7-dimethyl-2,6-octadien-1-ol); Phenylethyl alcohol (2-phenylethanol); Rhodinol™ (3,7-dimethyloct-6-en-1-ol); Sandalore™ (3-methyl terpineol (2-(4-methylcyclohex-3-en-1-yl)propan-2-ol); or Timberol™ (1-(2,2,6-trimethylcyclohexyl)hexan-3-ol); 2,4,7-trimethylocta-2,6-dien-1-ol, and / or [1-methyl-2(5-methylhex-4-en-2-yl)cyclopropyl]-methanol;
[0021] - aldehydes and ketones, such as anisaldehyde (4-methoxybenzaldehyde), alpha amyl cinnamaldehyde (2-benzylideneheptanal), Georgywood™ (1-(1,2,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone); hydroxycitronellal (7-hydroxy-3,7-dimethyloctanal); Iso E Super® (1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone); Isoraldeine® ((E)-3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one); Hedione™ (methyl 3-oxo-2-pentylcyclopentane acetate); 3-(4-isobutyl-2-methylphenyl)propanal; maltol; methyl cedryl ketone (1-((3R,3AR,7R,8aS)-3,6,8,8-tetramethyl-2,3,4,7,8,8a-hexahydro-1H-3a,7-methanoazulen-5-yl)ethan-1-one); methyl ionone; verbenone; and / or vanillin;
[0022] ethers and acetals, such as Ambrox® (3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1H-benzo[e][1]benzofuran); geranyl methyl ether ((2E)-1-methoxy-3,7-dimethylocta-2,6-diene); and / or Spirambrene® (2',2',3,7,7-pentamethylspiro[bicyclo[4.1.0]heptane-2,5'-[1,3]dioxane]);
[0023] esters and lactones, such as, for example, benzyl acetate; cedryl acetate ((1S,6R,8aR)-1,4,4,6-tetramethyloctahydro-1H-5,8a-methanoazulen-6-yl acetate); delta-decalactone (6-pentyltetrahydro-2H-pyran-2-one); Helvetolide® (2-(1-(3,3-dimethylcyclohexyl)ethoxy)-2-methylpropylpropionate); delta-undecalactone (5-heptyloxolan-2-one); and / or vetiberyl acetate ((4,8-dimethyl-2-propan-2-ylidene-3,3a,4,5,6,8a-hexahydro-1H-azulen-6-yl) acetate);
[0024] macrocycles, such as ambrettolide ((Z)-oxacycloheptadec-10-en-2-one); (E)-oxacycloheptadec-10-en-2-one; ethylene brassylate (1,4-dioxacycloheptadecane-5,17-dione); and / or Exaltolide® (16-oxacyclohexadecane-1-one); and heterocycles, for example isobutylquinoline (2-isobutylquinoline).
[0025] Thus, in a further aspect of the present invention there is provided a fragrance composition comprising a compound of formula (I) and at least one other odorant molecule.
[0026] The compounds of formula (I) can be used in a wide range of fragranced articles, for example, in the fields of fine and functional perfumery, such as perfumes, air care products, household products, laundry products, body care products, and cosmetics. The compounds can be employed in widely varying amounts, depending on the particular article, and the nature and amount of other fragrance ingredients. The proportion is typically 0.00001 to 3 weight percent of the article. In one embodiment, the compounds may be used in fabric softeners in an amount of 0.0001 to 0.3 weight percent (e.g., 0.001 to 0.1, including 0.05 weight percent). In another embodiment, the compounds may be used in fine prefumery in an amount of 0.01 to 30 weight percent (e.g., up to about 10 weight percent, or up to 20 weight percent), more preferably 0.01 to 5 weight percent (e.g., 0.01 to 0.1 weight percent). However, the skilled perfumer may achieve effects at lower or higher concentrations or create new accords, and these values are given as examples only.
[0027] The compounds of formula (I) may be applied to the consumer product base by simply mixing the compound, or a fragrance composition comprising a compound of formula (I), or mixtures thereof, directly with the consumer product base, or may be entrapped at an earlier stage in an entrapment material, for example polymers, capsules, microcapsules and nanocapsules, liposomes, film formers, absorbents such as carbon or zeolites, cyclic oligosaccharides, and mixtures thereof, and then mixed with the consumer product base.
[0028] Thus, the present invention further provides a method of producing a perfumed article comprising the incorporation of a compound of formula (I) or mixtures thereof as a fragrance ingredient, either by direct mixing with the consumer product base, or by mixing a fragrance composition comprising a compound of formula (I) or mixtures thereof, which may then be mixed with the consumer product base using conventional techniques and methods. Through the addition of an olfactory acceptable amount of a compound of formula (I) or mixtures thereof, the odor notes of the consumer product base are improved, enhanced or modified.
[0029] Thus, the present invention further provides a method for improving, enhancing or modifying a consumer product base by the addition to the consumer product base of an olfactory acceptable amount of a compound of formula (I) or a mixture thereof.
[0030] In a further aspect of the invention, a) A compound represented by formula (I) [ka] During the ceremony, X is a divalent residue -(CH2) optionally substituted with one additional methyl group. n- and Y is a divalent residue -(CH2) m - and n is an integer selected from 3 to 12, and m is an integer selected from 3 to 12; provided that n+m is at least 13 and not greater than 15, e.g., n+m is 14; and b) Consumer product base A scented article is provided comprising:
[0031] As used herein, "consumer product base" refers to a composition for use as a consumer product that fulfills a specific function, such as cleaning, softening, and care.Examples of such products include luxury perfumes, such as perfume and eau de toilette; cosmetics, fabric care, household and personal care products, such as laundry care detergents, rinse conditioners, personal cleansing compositions, dishwashing detergents, surface cleaners, etc.; laundry products, such as fabric softeners, bleaches, detergents; body care products, such as shampoos, shower gels; air care products, including products that contain compounds that are preferably volatile and usually have a pleasant odor, and can advantageously mask unpleasant odors even in very small amounts.Air fresheners for living areas contain natural and synthetic essential oils, such as pine oil, citrus oil, eucalyptus oil, lavender oil, etc., in amounts of, for example, up to 50% by weight. As aerosols, they tend to contain smaller amounts of such essential oils, e.g., less than 5% or less than 2% by weight, but further include compounds such as acetaldehyde (especially <0.5% by weight), isopropyl alcohol (especially <5% by weight), mineral oil (especially <5% by weight), and propellants.
[0032] Cosmetics include: (a) cosmetic and skin care products, in particular bath products, skin washing and cleansing products, skin care products, eye make-up, lip care products, nail care products, intimate care products and foot care products; (b) Cosmetic products with specific functions, in particular sunscreens, tanning products, depigmenting products, deodorants, antiperspirants, depilatories and shaving products; (c) Cosmetic dental care products, in particular dental and oral care products, tooth care products, cleaners for dental prostheses, adhesives for dental prostheses; and (d) Cosmetic hair-care products, in particular hair shampoos, hair-care products, hair-styling products, hair-shaping products and hair-colouring products.
[0033] This list of products is given by way of example and is not to be construed as limiting in any way. In one particular embodiment, the consumer product base is selected from fine fragrances and personal care products including deodorants, hair care products, soaps, and the like.
[0034] In further specific embodiments, the consumer product base is selected from fabric care products, including fabric softeners, and home care products, including air fresheners, dishwashers, and the like.
[0035] Most of the compounds of formula (I) are novel per se. Thus, according to a further aspect of the present invention, a compound of formula (I) [ka] During the ceremony, X is a divalent residue -(CH2) optionally substituted with one additional methyl group. n- and Y is a divalent residue -(CH2) m - and n is an integer selected from 3 to 7, and m is an integer selected from 8 to 11; provided that n+m is at least 13 and not more than 15 (e.g., n+m is 4); and However, oxacyclohexadecan-6-one and oxacyclohexadecan-5-one are excluded. is provided.
[0036] Compounds of formula (I) may be synthesized, for example, from the respective oxa diacid or oxa diester by Dieckmann reaction and in situ decarboxylation. The oxa diester or oxa diacid may be obtained by oxidation of the corresponding primary oxa diol (e.g., by reaction with chromium trioxide in sulfuric acid). Synthesis of the ether bond may be accomplished by reacting a mono-protected (e.g., benzyl-protected) diol with a mono-protected (e.g., benzyl-protected), mono-activated (e.g., toluenesulfonyl) diol. After formation of the ether bond, deprotection provides the desired oxa diol.
[0037] Compounds of formula (I) in which X is a divalent residue substituted with one methyl group may also be prepared by converting a suitable unsaturated ether into the respective diester, for example by hydrocarbonylation, followed by a Dieckmann reaction and in situ decarboxylation.
[0038] The invention will now be further described with reference to the following non-limiting examples, which are for illustrative purposes only, and it will be understood that variations and modifications may be made by those skilled in the art. EXAMPLES
[0039] Example 1: 4-Methyloxacyclohexadecan-6-one Example 1a: 10-((3-Methylbut-3-en-1-yl)oxy)dec-1-ene: A suspension of sodium hydride (0.65 g, 60 wt% in mineral oil, 16.2 mmol) in tetrahydrofuran (THF) (30 mL) was slowly treated with a solution of 3-methylbut-3-en-1-ol (1.20 g, 1.41 mL, 97 wt%, 13.5 mmol) in THF (10 mL) at room temperature (rt). After addition, the mixture was heated to 60° C. and stirred for 1 h, then treated with 10-bromodec-1-ene (3.55 g, 16.2 mmol) and the resulting mixture was stirred at 60° C. overnight. After cooling to room temperature, the mixture was poured onto ice water (50 mL), extracted with MTBE (methyl tert-butyl ether) (2×80 mL), washed with water (80 mL) and brine (50 mL), dried over Na2SO4, filtered and concentrated. The resulting material was purified by flash column chromatography on silica gel eluted with a gradient of MTBE in heptane to give 10-((3-methylbut-3-en-1-yl)oxy)dec-1-ene (1.6 g, 7.13 mmol, 53% yield) as a yellow liquid.
[0040] 1H NMR (400 MHz, CDCl3, 298 K) δ (ppm) = 5.83 (tdd, J = 6.6, 10.3, 17.1 Hz, 1H), 5.01 (qd, J = 1.8, 17.1 Hz, 1H), 4.95 (tdd, J = 1.2, 2.3, 10.2 Hz, 1H), 4.82 - 4.72 (m, 2H), 3.54 (t, J = 7.1 Hz, 2H), 3.44 (t, J = 6.7 Hz, 2H), 2.32 (t, J = 7.0 Hz, 2H), 2.10 - 2.02 (m, 2H), 1.77 (s, 3H), 1.59 (quin, J = 7.0 Hz, 2H), 1.45 - 1.26 (m, 10H). 13C NMR (101 MHz, CDCl3, 298 K) δ (ppm) = 143.0, 139.2, 114.1, 111.3, 71.0, 69.3, 37.8, 33.8, 29.7, 29.4, 29.4, 29.1, 28.9, 26.2, 22.8. GC / MS (EI, 70eV): 209 (2, [M-CH3] + ), 169 (1), 155 (1), 109 (9), 99 (36), 83 (74), 70 (100), 69 (63), 55 (95).
[0041] Example 1b: Methyl 11-((5-methoxy-3-methyl-5-oxopentyl)oxy)undecanoate: A solution of 10-((3-methylbut-3-en-1-yl)oxy)dec-1-ene (1.60 g, 7.13 mmol) in methanol (15 mL) was treated with bis(acetonitrile)dichloropalladium(II) (93.4 mg, 99 wt%, 357 μmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphane) (213 mg, 97 wt%, 357 μmol) and methanesulfonic acid (69.2 mg, 99 wt%, 713 μmol) in an autoclave and the resulting mixture was flushed with carbon monoxide (CO) and then pressurized to 15 bar with CO and heated at 80° C. for 20 h. The mixture was then cooled to room temperature, the gas pressure was carefully released, and the mixture was poured into ice water (100 mL), extracted with EtOAc (2×50 mL), washed with water (50 mL), brine (50 mL), dried over Na2SO4, filtered, and concentrated. The resulting material was purified by flash column chromatography on silica gel eluted with a gradient of MTBE in heptane to give methyl 11-((5-methoxy-3-methyl-5-oxopentyl)oxy)undecanoate (1.40 g, 3.43 mmol, 48% yield) along with the other regioisomer as a pale yellow oil, which was used in the next step without further purification.
[0042] GC / MS (EI, 70eV): 344 (1, [M] +*), 312 (1), 280 (2), 271 (2), 215 (12), 199 (4), 183 (20), 145 (61), 129 (75), 113 (100) 101 (22), 97 (25), 87 (49), 69 (66), 59 (21), 55 (41), 41 (25).
[0043] Example 1c: Mixture of methyl 4-methyl-6-oxooxacyclohexadecane-7-carboxylate and methyl 4-methyl-6-oxooxacyclohexadecane-5-carboxylate: A solution of methyl 11-((5-methoxy-3-methyl-5-oxopentyl)oxy)undecanoate (1.40 g, 4.06 mmol) in THF (180 ml) was added dropwise over 6.5 hours to a refluxing mixture of NaHMDS (sodium hexamethyldisilazide) (8.94 g, 24.4 mL, 2.0 molar in THF, 48.8 mmol) and THF (120 ml). The reaction was then refluxed for a further 30 minutes, then cooled to room temperature and slowly treated with acetic acid (AcOH) (20 mL). The mixture was then washed with water (3×150 mL) and the washings were extracted with MTBE (200 mL). The combined organic layers were washed with brine (150 mL), dried over Na2SO4, filtered and concentrated. The resulting material was purified by flash column chromatography on silica gel eluted with a gradient of MTBE in heptane to give a mixture of methyl 4-methyl-6-oxooxacyclohexadecane-7-carboxylate and methyl 4-methyl-6-oxooxacyclohexadecane-5-carboxylate (0.190 g, 89% purity, 13% yield), which was carried on to the next step without further purification. GC / MS (EI, 70eV): 312 (1, [M] + *), 281 (3), 170 (5), 115 (100).
[0044] Example 1d: 4-Methyloxacyclohexadecan-6-one: A solution of a mixture of methyl 4-methyl-6-oxooxacyclohexadecane-7-carboxylate and methyl 4-methyl-6-oxooxacyclohexadecane-5-carboxylate (0.17 g, 0.54 mmol) in MeOH (5 ml) was treated with aqueous NaOH (0.82 mL, 2 molar, 1.6 mmol) and the resulting mixture was heated to reflux (80° C.) for 1 h. The resulting mixture was cooled to room temperature, acidified to pH 1 by dropwise addition of 10% H2SO4, and then heated to reflux for 30 min. The mixture was then cooled to room temperature, extracted with MTBE (2×50 mL), washed with water (50 mL), brine (50 mL), dried over Na2SO4, filtered, and concentrated. The resulting material was purified by flash column chromatography on silica gel eluted with a gradient of MTBE in heptane to give 4-methyloxacyclohexadecan-6-one (0.100 g, 98% purity, 0.54 mmol, 71% yield) as a colorless liquid.
[0045] 1H NMR (400 MHz, CDCl3, 298 K) δ (ppm) = 3.53 - 3.35 (m, 4H), 2.57 (dd, J = 5.9, 14.1 Hz, 1H), 2.49 - 2.35 (m, 2H), 2.34 - 2.21 (m, 1H), 2.20 - 2.11 (m, 1H), 1.76 - 1.21 (m, 18H), 0.93 (d, J = 6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3, 298 K) δ (ppm) = 212.2, 70.3, 68.0, 50.7, 40.7, 36.6, 29.1, 27.1, 27.0, 26.9, 26.8, 25.9, 25.8, 25.0, 22.4, 20.0. GC / MS (EI, 70eV): 254 (6, [M] + *), 239 (1), 167 (4), 149 (6), 125 (37), 115 (63), 97 (100), 83 (26), 69 (53), 55 (63), 41 (54).
[0046] Odor description (10% solution in DPG on paper blotter, 4 hours): musky, powdery, nitro musk.
[0047] Example 2: Oxacyclopentadecan-6-one Example 2a: Methyl 10-((5-methoxy-5-oxopentyl)oxy)decanoate: A mixture of 1,7-dioxacycloheptadecan-8-one (58.33 g, 228 mmol) and NaOH (10.94 g, 273 mmol) in water (100 mL) was refluxed for 4 h. After complete conversion of starting lactone (monitored by GC and TLC), the mixture was cooled to room temperature and then dilute HCl was added dropwise to obtain pH=6-7. The mixture was then cooled to 0°C and then KMnO4 (43.20 g, 273 mmol) was added portionwise to the reaction mixture at 0°C and the resulting mixture was stirred at room temperature overnight. The mixture was then filtered and the filtrate was treated dropwise with 2M HCl to obtain pH=4-5 while forming a white precipitate. The precipitate was filtered to give the crude diacid (70.01 g) as a white solid. The solid was mixed with methanol (100 mL) and treated with 2 drops of concentrated sulfuric acid. The reaction mixture was stirred under reflux for 2 h and then cooled to room temperature. The solvent was evaporated and the resulting oil was purified by column chromatography on silica gel eluted with a gradient of MTBE in heptane to give methyl 10-((5-methoxy-5-oxopentyl)oxy)decanoate (19.37 g, 61 mmol, 27% yield) as a colorless oil.
[0048] 1H NMR (400 MHz, CDCl3) δ (ppm) = 3.68, 3.66 (s, 6H), 3.52 - 3.20 (m, 4H), 2.37 - 2.25 (m, 4H), 1.81 - 1.42 (m, 8H), 1.38 - 1.22 (m, 10H). 13C NMR (101 MHz, CDCl3) δ (ppm) = 174.23(s), 173.99(s), 70.96(t), 70.23(t), 51.40(q), 51.36(q), 34.05(t), 33.78(t), 29.70(t), 29.37(t), 29.33(t), 29.14(t), 29.08(t), 26.12(t), 24.90(t), 21.75(t). GC / MS (EI): m / z (%): 284 (1) [M+], 252 (4), 201 (17), 169 (42), 131 (77), 115 (94), 101 (86), 99 (97), 83 (65), 73 (50), 55 (100).
[0049] Example 2b: Mixture of methyl 6-oxooxacyclopentadecane-7-carboxylate and methyl 6-oxooxacyclopentadecane-5-carboxylate: A solution of methyl 10-((5-methoxy-5-oxopentyl)oxy)decanoate (6.00 g, 17 mmol) in THF (340 mL) was slowly added at a rate of 50 mL / hr to a refluxing mixture of LiHMDS (lithium hexamethyldisilazide) (180 mL, 1 M in THF, 180 mmol) and THF (220 mL) under argon. After completion of the feed, the mixture was stirred under reflux for an additional 15 min. The mixture was then cooled to room temperature and treated with dilute HCl to obtain pH=4-5, extracted with MTBE (3×200 mL), washed with water (200 mL), brine (200 mL), dried over MgSO4, and concentrated. The obtained crude oil was purified by column chromatography on silica gel eluted with a gradient of MTBE in heptane to give a mixture of methyl 6-oxooxacyclopentadecane-7-carboxylate and methyl 6-oxooxacyclopentadecane-5-carboxylate (2.30 g, 8.1 mmol, 43% yield, ratio of two isomers = 1.3:1) as a pale yellow oil.
[0050] 1H NMR (400 MHz, CDCl3) δ (ppm) = 3.71 (s, 3H), 3.66 - 3.57 (m, 1H), 3.54 - 3.30 (m, 4H), 2.82 - 2.43 (m, 2H), 2.18 - 1.86 (m, 2H), 1.85 - 1.68 (m, 3H), 1.64 - 1.51 (m, 4H), 1.42 - 1.28 (m, 9H). 13C NMR (101 MHz, CDCl3) δ (ppm) = 207.05(s), 206.58(s), 170.34(s), 170.25(s), 70.57(t), 70.33(t), 70.21(t), 69.81(t), 58.40(d), 57.23(d), 52.26(q), 52.22(q), 42.87(t), 40.51(t), 28.92(t), 28.80(t), 28.37(t), 28.09(t), 27.53(t), 27.19(t), 27.00(t), 26.98(t), 26.74(t), 26.41(t), 26.17(t), 25.54(t), 25.40(t), 25.30(t), 25.12(t), 23.23(t), 21.64(t). Major GC / MS (EI): m / z (%): 284 (1) [M+], 253 (5), 207 (6), 156 (10), 115 (33), 100 (73), 83 (33), 69 (38), 55 (100)., Minor GC / MS (EI): m / z (%): 284 (1) [M+], 253 (3), 207 (1), 156 (10), 110 (9), 101 (100), 83 (36), 69 (16), 55 (65).
[0051] Example 2c: Oxacyclopentadecan-6-one: A mixture of methyl 6-oxooxacyclopentadecane-7-carboxylate and methyl 6-oxooxacyclopentadecane-5-carboxylate (2.50 g, 8 mmol) was dissolved in MeOH (100 mL) and treated with a solution of NaOH (0.96 g, 24 mmol) in water (100 mL) at room temperature, and the resulting mixture was refluxed for 1 h. After cooling, the mixture was acidified with 10% H2SO4 to pH=3-4, followed by refluxing for 30 min. The mixture was then cooled to room temperature and concentrated under reduced pressure to remove MeOH. The residue was extracted with MTBE (3×100 mL), washed with water (100 mL), brine (100 mL), dried over MgSO4, and concentrated. The resulting material was purified by column chromatography on silica gel eluting with a gradient of MTBE in heptane, followed by Kugelrohr distillation (190 °C, 0.082 MPa) to give oxacyclopentadecan-6-one (1.76 g, 7.4 mmol, 92% yield) as a colorless oil.
[0052] 1H NMR (400 MHz, CDCl3) δ (ppm) = 3.49 - 3.36 (m, 4H), 2.58 - 2.48 (m, 2H), 2.47 - 2.37 (m, 2H), 1.79 - 1.63 (m, 4H), 1.60 - 1.48 (m, 3H), 1.47 - 1.20 (m, 11H). 13C NMR (101 MHz, CDCl3) δ (ppm) = 213.12(s), 70.49(t), 70.18(t), 43.12(t), 41.45(t), 28.97(t), 28.78(t), 27.31(t), 27.05(t), 26.58(t), 26.29(t), 25.12(t), 24.08(t), 21.96(t). GC / MS (EI): m / z (%): 226 (8) [M+], 135 (7), 111 (26), 101 (55), 98 (90), 83 (75), 81 (20), 69 (30), 55 (100). Odor description (10% solution in DPG on blotting paper, 4 hours): Musky, powdery, nitro musk.
[0053] Example 3: Oxacyclohexadecan-9-one Example 3a: 8-(benzyloxy)octyl 4-methylbenzenesulfonate: A flask was charged with 8-(benzyloxy)octan-1-ol (10.0 g, 42.3 mmol), dichloromethane (100 mL), Et3N (trimethylamine) (5.19 g, 7.15 mL, 50.8 mmol) and the reaction mixture was cooled to 0° C. (ice bath). Finally, p-toluenesulfonyl chloride (9.78 g, 50.8 mmol) was added portionwise over 30 min and the reaction mixture was stirred at 0° C. for 30 min and then at room temperature for 17 h (overnight). The reaction mixture was poured into ice-cold HCl 1M (150 ml) and stirred vigorously for 10 min. The mixture was extracted with MTBE (2×150 ml), washed with saturated NaHCO3 solution (1×150 ml) and brine (1×100 ml), dried over Na2SO4, filtered and concentrated under reduced pressure to give 8-(benzyloxy)octyl 4-methylbenzenesulfonate (17.7 g, 94% purity, 42.5 mmol, quantitative yield) as a yellow oil which was used without further purification. GC / MS (EI, 70eV): 390 (1, [M] + *), 372 (1), 218 (1), 173 (33), 155 (6), 107 (37), 91 (100).
[0054] Example 3b: (((oxybis(octane-8,1-diyl))bis(oxy))bis(methylene))dibenzene: A suspension of sodium hydride (2.5 g, 60 wt% in mineral oil, 62.2 mmol) in THF (100 ml) was treated with a solution of 8-(benzyloxy)octan-1-ol (14.0 g, 59.2 mmol) in THF (50 ml) at room temperature over 30 min and the resulting reaction mixture was heated at 60° C. for 1 h. Finally, a solution of 8-(benzyloxy)octyl 4-methylbenzenesulfonate (24.3 g, 62.2 mmol) in THF (50 ml) was added over 45 min. The reaction mixture was stirred at room temperature for 17 h and then at 60° C. for 23 h. The reaction mixture was poured into ice water (200 ml) and stirred vigorously for 10 min. The mixture was then extracted with MTBE (2×200 ml) and the organic layers were washed with water (1×200 ml) and brine (1×150 ml). The combined organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure to give the product purified by column chromatography on silica gel eluted with a gradient of MTBE in heptane to give (((oxybis(octane-8,1-diyl))bis(oxy))bis(methylene))dibenzene (19.0 g, 41.8 mmol, 71% yield) as a colorless oil.
[0055] 1H NMR (400 MHz, CDCl3, 298 K) δ (ppm) = 7.37 - 7.30 (m, 8H), 7.30 - 7.23 (m, 2H), 4.49 (s, 4H), 3.45 (t, J = 6.6 Hz, 4H), 3.38 (t, J = 6.7 Hz, 4H), 1.65 - 1.50 (m, 8H), 1.40 - 1.26 (m, 16H). 13C NMR (101 MHz, CDCl3, 298 K) δ (ppm) = 138.7, 128.3, 127.6, 127.5, 72.9, 71.0, 70.5, 29.8, 29.5, 26.2. GC / MS (EI, 70eV): 363 (5, [M-CH2Ph] +*), 235 (1), 111 (13), 167 (9), 91 (100).
[0056] Example 3c: 8,8'-oxybis(octan-1-ol): A solution of (((oxybis(octane-8,1-diyl))bis(oxy))bis(methylene))dibenzene (19.0 g, 41.8 mmol) in methanol (250 mL) was treated with palladium on carbon (2.22 g, 10 wt% palladium, 2.09 mmol). The flask was placed under vacuum and purged with argon, then flushed with hydrogen gas to evacuate the argon. The mixture was stirred under H2 atmosphere (balloon pressure) at room temperature for 20 h, then flushed with argon gas to evacuate the hydrogen. The mixture was filtered through a short pad of silica, washed with EtOAc (2 x 100 ml) and the filtrate was concentrated under reduced pressure to give 8,8'-oxybis(octan-1-ol) (11.05 g, 40.2 mmol, 96% yield) as a beige solid.
[0057] 1H NMR (400 MHz, CDCl3, 298 K) δ (ppm) = 3.62 (t, J = 6.7 Hz, 4H), 3.39 (t, J = 6.7 Hz, 4H), 1.95 (br s, 2H), 1.64 - 1.48 (m, 8H), 1.41 - 1.26 (m, 16H). 13C NMR (101 MHz, CDCl3, 298 K) δ (ppm) = 70.9, 62.9, 32.7, 29.7, 29.4, 29.4, 26.1, 25.7. GC / MS (EI, 70eV): 256 (1, [M-H2O] + *), 145 (17), 129 (6), 127 (14), 109 (46), 69 (100).
[0058] Example 3d: 8,8'-oxydioctanoic acid: A solution of 8,8'-oxybis(octan-1-ol) (10.0 g, 36.4 mmol) in acetone (200 mL) was treated at room temperature (water bath cooling) with Jones reagent (67 g, 52 mL, 36.4 mmol) dropwise over 60 min until the reaction mixture showed an orange color. After stirring at room temperature for 2 h, the reaction mixture was quenched with isopropanol (50 ml). The reaction mixture was poured into ice-cold 2M NaOH (150 ml) and stirred vigorously for 10 min. The mixture was extracted with EtOAc (1 x 150 ml) and the organic layer was discarded. The aqueous layer was then acidified to pH 1 with HCl 5M, filtered, extracted with CHCl (2 x 200 ml) and the organic layer was washed with brine (1 x 150 ml). The combined organic layers were dried over Na2SO4, filtered and concentrated under reduced pressure to give 8,8'-oxydioctanoic acid (9.40 g, 80% purity, 25 mmol, 69% yield) as a white solid, which was used without further purification.
[0059] 1H NMR (400 MHz, CDCl3, 298 K) δ (ppm) = 10.29 (br s, 2H), 3.40 (t, J = 6.7 Hz, 4H), 2.34 (t, J = 7.5 Hz, 4H), 1.72 - 1.49 (m, 8H), 1.44 - 1.23 (m, 12H). 13C NMR (101 MHz, CDCl3, 298 K) δ (ppm) = 180.1, 70.8, 34.1, 29.6, 29.0, 29.0, 26.0, 24.6.
[0060] Example 3e: Dimethyl 8,8'-oxydioctanoate: A mixture of 8,8'-oxydioctanoate (9.40 g, 31.1 mmol), methanol (200 mL) and one drop of sulfuric acid (311 mg, 0.169 mL, 3.11 mmol) was heated to 65 °C and stirred for 3.5 h. The reaction mixture was poured into ice water (200 ml) and stirred vigorously for 10 min. The mixture was extracted with MTBE (2 x 150 ml) and the organic layer was washed with water (1 x 150 ml), saturated aqueous NaHCO3 (1 x 100 ml) and brine (1 x 100 ml). The combined organic layers were dried over Na2SO4, filtered and concentrated under reduced pressure to give dimethyl 8,8'-oxydioctanoate (9.40 g, 95% pure, 29.2 mmol, 94% yield) as a pale yellow liquid.
[0061] 1H NMR (400 MHz, CDCl3, 298 K) δ (ppm) = 3.66 (s, 6H), 3.38 (t, J = 6.7 Hz, 4H), 2.30 (t, J = 7.5 Hz, 4H), 1.70 - 1.49 (m, 8H), 1.40 - 1.26 (m, 12H). 13C NMR (101 MHz, CDCl3, 298 K) δ (ppm) = 174.2, 70.9, 51.4, 34.0, 29.7, 29.1, 29.1, 26.0, 24.9. GC / MS (EI, 70eV): 299 (1, [M-MeO] + *), 281 (1), 267 (1), 257 (3), 173 (48), 157 (26), 141 (100), 125 (80), 59 (19), 55 (69).
[0062] Example 3f: Methyl 9-oxooxacyclohexadecane-8-carboxylate: A solution of dimethyl 8,8'-oxydioctanoate (5.00 g, 15.1 mmol) in THF (270 ml) was added to a gently refluxing mixture of NaHMDS (27.7 g, 75.6 mL, 2.0 molar in THF, 151 mmol) and THF (450 ml) over 6 hours under N2 atmosphere. After addition, the reaction mixture was refluxed for an additional hour, then cooled to room temperature and slowly treated with acetic acid (50 ml). The reaction mixture was washed with water (2 x 250 ml) and the aqueous layer was extracted with MTBE (250 ml). Finally, the organic layer was washed with brine (1 x 200 ml), dried over Na2SO4, filtered and concentrated under reduced pressure. The resulting material was purified by column chromatography on silica gel eluted with a gradient of MTBE in heptane to give methyl 9-oxooxacyclohexadecane-8-carboxylate (1.60 g, 96% purity, 4.90 mmol, 32% yield) as a pale yellow liquid.
[0063] 1H NMR (400 MHz, CDCl3, 298 K) δ (ppm) = 3.77 - 3.65 (m, 3H), 3.57 (dd, J = 6.5, 8.4 Hz, 1H), 3.51 - 3.35 (m, 4H), 2.64 - 2.47 (m, 2H), 2.05 - 1.79 (m, 2H), 1.78 - 1.19 (m, 18H). 13C NMR (101 MHz, CDCl3, 298 K) δ (ppm) = 206.6, 170.2, 69.4, 69.4, 57.6, 52.2, 40.7, 29.0, 28.9, 27.8, 27.6, 27.5, 27.3, 26.6, 25.5, 25.4, 22.8. GC / MS (EI, 70eV): 298 (2, [M] + *), 283 (1), 280 (1), 267 (9), 248 (2), 238 (1), 125 (58), 98 (46), 87 (34), 55 (100), 41 (37).
[0064] Example 3g: Oxacyclohexadecan-9-one: A solution of methyl 9-oxooxacyclohexadecane-8-carboxylate (1.6 g, 5.4 mmol) in MeOH (50 ml) was treated with aqueous NaOH (0.64 g, 8.0 mL, 2 molar, 16 mmol) and the resulting mixture was heated to reflux (80° C.) for 1 h. The resulting mixture was cooled to room temperature and acidified to pH 1 by dropwise addition of 10% H2SO4, then heated to reflux again for 30 min. The mixture was then cooled to room temperature, extracted with MTBE (2×100 mL), washed with water (100 mL), brine (100 mL), dried over Na2SO4, filtered and concentrated. The resulting material was purified by flash column chromatography on silica gel eluted with a gradient of MTBE in heptane to give oxacyclohexadecan-9-one (1.0 g, 4.2 mmol, 77% yield) as a pale yellow liquid.
[0065] 1H NMR (400 MHz, CDCl3, 298 K) δ (ppm) = 3.48 - 3.38 (m, 4H), 2.41 (t, J = 7.2 Hz, 4H), 1.74 - 1.62 (m, 4H), 1.60 - 1.50 (m, 4H), 1.49 - 1.39 (m, 4H), 1.38 - 1.26 (m, 8H). 13C NMR (101 MHz, CDCl3, 298 K) δ (ppm) = 212.8, 69.4, 41.5, 29.0, 27.9, 27.3, 25.4, 23.5. GC / MS (EI, 70eV): 240 (5, [M] + *), 225 (1), 197 (1), 153 (11), 125 (45), 97 (45), 82 (58), 55 (100), 41 (54), 29 (15). Odor description (10% solution in DPG on blotting paper, 4 hours): Musky, powdery, nitro musk, warm.
[0066] Examples 4a-4e: Following the general procedure described in Example 3, compounds 4a-4e were prepared.
[0067] 4a: Oxacyclohexadecan-8-one: In the first step (tosylation), 9-(phenylmethoxy)-1-nonanol was used, which was then reacted with 7-(phenylmethoxy)-1-heptanol, followed by the steps described, to give oxacyclohexadecan-8-one as a pale yellow oil.
[0068] 1 H NMR (400 MHz, CDCl3) δ (ppm) = 3.44 - 3.23 (m, 4H), 2.52 - 2.18 (m, 4H), 1.72 - 1.52 (m, 4H), 1.52 - 1.39 (m, 4H), 1.38 - 1.15 (m, 12H). 13 C NMR (101 MHz, CDCl3) δ (ppm) = 211.59(q), 68.99(t), 68.64(t), 41.02(t), 40.64(t), 28.30(t), 27.96(t), 27.08(t), 26.51(t), 26.21(t), 26.09(t), 25.03(t), 24.04(t), 22.64(t), 22.36(t). GC / MS (EI): m / z (%): 240 (5) [M+], 139 (17), 126 (18), 111 (28), 97 (26), 83 (33), 81 (25), 69 (45), 55 (100).
[0069] Odor description (10% solution in DPG on blotting paper, 4 hours): Musky, powdery, nitro musk, warm.
[0070] 4b: Oxacycloheptadecan-7-one:In the first step (tosylation), 6-(benzyloxy)-1-hexanol was used, which was then reacted with 11-(phenylmethoxy)-1-undecanol, followed by the steps described, to give oxacycloheptadecan-7-one as a colorless liquid.
[0071] 1 H NMR (500 MHz, CDCl3, 298 K) δ (ppm) = 3.45 - 3.37 (m, 4H), 2.43 (t, J = 6.7 Hz, 2H), 2.40 (t, J = 6.9 Hz, 2H), 1.68 - 1.59 (m, 4H), 1.58 - 1.49 (m, 4H), 1.45 - 1.35 (m, 4H), 1.35 - 1.23 (m, 10H). 13 C NMR (126 MHz, CDCl3, 298 K) δ (ppm) = 212.4, 70.3, 70.2, 42.5, 42.5, 29.8, 29.2, 27.9, 27.9, 27.5, 27.2, 27.1, 26.6, 25.6, 24.1, 23.3. GC / MS (EI, 70eV): 254 (5, [M] + *), 236 (1), 211 (1), 125 (23), 112 (26), 97 (35), 83 (21), 69 (48), 55 (100), 41 (70).
[0072] Odor description (10% solution in DPG on blotter paper, 4 hours): musky, powdery, nitro musk, slightly ambery.
[0073] 4c: Oxacycloheptadecan-6-one: In the first step (tosylation), 5-(benzyloxy)-1-pentanol was used, which was then reacted with 12-(phenylmethoxy)-1-dodecanol, followed by the steps described, to give oxacycloheptadecan-6-one as a colorless liquid.
[0074] 1 H NMR (500 MHz, CDCl3, 298 K) δ (ppm) = 3.47 - 3.39 (m, 4H), 2.49 - 2.39 (m, 4H), 1.77 - 1.69 (m, 2H), 1.68 - 1.58 (m, 4H), 1.58 - 1.51 (m, 2H), 1.47 - 1.38 (m, 2H), 1.37 - 1.26 (m, 12H). 13 C NMR (126 MHz, CDCl3, 298 K) δ (ppm) = 212.7, 70.3, 43.1, 41.9, 29.4, 29.4, 27.6, 27.3, 27.2, 26.9, 25.5, 23.6, 22.1. GC / MS (EI, 70eV): 254 (5, [M] + *), 236 (1), 225 (1), 111 (32), 98 (82), 83 (60), 69 (22), 55 (100), 41 (65).
[0075] Odor description (10% solution in DPG on blotting paper, 4 hours): Musky, powdery, nitro musk, slightly ambery.
[0076] 4d: Oxacycloheptadecan-9-one: In the first step (tosylation), 8-(benzyloxy)-1-octanol was used, which was then reacted with 9-(phenylmethoxy)-1-nonanol, followed by the steps described, to give oxacycloheptadecan-9-one as a colorless liquid.
[0077] 1 H NMR (500 MHz, CDCl3, 298 K) δ (ppm) = 3.46 - 3.37 (m, 4H), 2.47 - 2.35 (m, 4H), 1.70 - 1.59 (m, 4H), 1.58 - 1.50 (m, 4H), 1.47 - 1.38 (m, 4H), 1.38 - 1.22 (m, 10H). 13 C NMR (126 MHz, CDCl3, 298 K) δ (ppm) = 212.9, 70.0, 69.9, 42.9, 41.9, 29.5, 29.4, 28.7, 28.3, 28.2, 28.2, 25.8, 24.1, 23.8. GC / MS (EI, 70eV): 254 (3, [M] + *), 239 (1), 211 (1), 197 (1), 171 (2), 153 (4), 139 (9), 125 (15), 111 (14), 97 (26), 82 (24), 69 (24), 55 (100), 41 (55).
[0078] Odor description (10% solution in DPG on blotting paper, 4 hours): Musky, powdery, nitro musk, slightly ambery, warm.
[0079] 4e: Oxacycloheptadecan-8-one: In the first step (tosylation), 7-(benzyloxy)-1-heptanol was used, which was then reacted with 10-(phenylmethoxy)-1-decanol, followed by the steps described, to give oxacycloheptadecan-8-one as a colorless liquid.
[0080] 1 H NMR (500 MHz, CDCl3, 298 K) δ (ppm) = 3.47 - 3.38 (m, 4H), 2.44 (t, J = 6.9 Hz, 2H), 2.42 - 2.38 (m, 2H), 1.71 - 1.61 (m, 4H), 1.59 - 1.51 (m, 4H), 1.46 - 1.24 (m, 14H). 13 C NMR (126 MHz, CDCl3, 298 K) δ (ppm) = 212.4, 70.2, 70.1, 42.1, 41.9, 29.4, 29.3, 28.4, 28.1, 28.0, 27.8, 27.4, 26.0, 25.9, 23.7, 23.5. GC / MS (EI, 70eV): 254 (4, [M] + *), 236 (1), 211 (1), 197 (2), 186 (3), 169 (2), 153 (3), 139 (9), 126 (16), 111 (22), 98 (15), 83 (24), 69 (36), 55 (100), 41 (58).
[0081] Odor description (10% solution in DPG on blotting paper, 4 hours): Musky, powdery, nitro musk, slightly ambery.
[0082] Example 5: Fragrance Composition [Table 1-1]
[0083] [Table 1-2]
[0084] By replacing 8 parts DPG with 8 parts oxacyclohexadecan-9-one (the compound represented by formula (I)), the fragrance composition felt rounder, blended better, and was warmer with musky notes, adding depth to the fragrance.
Claims
1. Compounds represented by formula (I) [Formula 1] During the ceremony, X is a divalent residue -(CH2) optionally substituted with one additional methyl group. n- and Y is a divalent residue -(CH2) m - and n is an integer selected from 3 to 12, and m is an integer selected from 3 to 12; with the proviso that n+m is at least 13 and not more than 15; and However, the compound represented by formula (I) is not oxacyclohexadecan-6-one. For use as a fragrance.
2. Compounds represented by formula (I) [chemical 2] During the ceremony, X is a divalent residue -(CH2) optionally substituted with one additional methyl group. n- and Y is a divalent residue -(CH2) m - and n is an integer selected from 3 to 12, and m is an integer selected from 3 to 12; with the proviso that n+m is at least 13 and not more than 15; and At least one other fragrance A fragrance composition comprising:
3. The compounds are 4-methyloxacyclopentadecan-6-one; 3-methyloxacyclopentadecan-5-one; oxacyclopentadecan-5-one; oxacyclopentadecan-6-one; oxacyclopentadecan-7-one; oxacyclopentadecan-8-one; 3-Methyloxacyclohexadecan-5-one; 10. A fragrance composition comprising a compound according to claim 1 selected from the group consisting of 4-methyloxacyclohexadecan-6-one; oxacyclohexadecan-5-one; oxacyclohexadecan-7-one; oxacyclohexadecan-8-one; oxacycloheptadecan-5-one; oxacycloheptadecan-6-one; oxacycloheptadecan-7-one; oxacycloheptadecan-8-one; and oxacycloheptadecan-9-one.
4. a) as an odorant, a compound represented by formula (I) [C3] During the ceremony, X is a divalent residue -(CH2) optionally substituted with one additional methyl group. n- and Y is a divalent residue -(CH2) m - and n is an integer selected from 3 to 12, and m is an integer selected from 3 to 12; with the proviso that n+m is at least 13 and not more than 15; and b) Consumer product base A fragrance article comprising:
5. 5. The perfumed article of claim 4, wherein the consumer product base is selected from fine perfumes, personal care products, and fabric care products.
6. Compounds represented by formula (I) [C4] During the ceremony, X is a divalent residue -(CH2) optionally substituted with one additional methyl group. n- and Y is a divalent residue -(CH2) m - and n is an integer selected from 3 to 12, and m is an integer selected from 3 to 12; with the proviso that n+m is at least 13 and not more than 15; and However, the compound represented by formula (I) is not oxacyclohexadecan-6-one.
16. A method of improving, enhancing or modifying a consumer product base by adding to the consumer product base an olfactory acceptable amount of
7. Compounds represented by formula (I) [C5] During the ceremony, X is a divalent residue -(CH2) optionally substituted with one additional methyl group. n- and Y is a divalent residue -(CH2) m - and n is an integer selected from 3 to 7, and m is an integer selected from 8 to 11; with the proviso that n+m is at least 13 and not more than 15; and However, oxacyclohexadecan-6-one and oxacyclohexadecan-5-one are excluded.
8. 4-methyloxacyclopentadecan-6-one; 3-methyloxacyclopentadecan-5-one; oxacyclopentadecan-5-one; oxacyclopentadecan-6-one; oxacyclopentadecan-7-one; oxacyclopentadecan-8-one; 3-Methyloxacyclohexadecan-5-one; 7. The compound of claim 6, which is selected from the group consisting of 4-methyloxacyclohexadecan-6-one; oxacyclohexadecan-7-one; oxacyclohexadecan-8-one; oxacycloheptadecan-5-one; oxacycloheptadecan-6-one; oxacycloheptadecan-7-one; oxacycloheptadecan-8-one; and oxacycloheptadecan-9-one.
Citation Information
Patent Citations
Fragrance Composition
JP2019529683A
Perfume compositions
JP2020002363A
Fragrance mixture containing tricyclo[5.2.1.0]-decane-8-ethyl ether
JP2020514515A
Synthetic substrates for enzymes that catalyze reactions of modified cysteines and related methods
US20180147250A1
